Drug
Mogamulizumab Kpkc
Mogamulizumab Kpkc: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Mogamulizumab-Kpkc NCT06235281 | Phase 1 | Mycosis Fungoides |
Latest
No recent events.
Follow Mogamulizumab Kpkc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.